Skip to main content
happyMD

Revolutionary Transdermal Delivery System

MODS Max™ Technology

A Comprehensive White Paper on Mineral Oxychloride Drug Synergy and Its Applications in Modern Medicine

Steven E. Warren, MD, DPA, FABFM, FABHPM, DASAM, CIME, CFMP

In partnership with Best365 Labs

2025 • Regenerative Wellness Centers

Why MODS Max?

MODS Max™ is a breakthrough technology that helps your body absorb supplements and medications more effectively - without needles or injections. Based on safe use by over 5,000 patients with zero serious side effects, this innovative system helps you get 5-10x better absorption of important health compounds like hormones, peptides, and nutrients.

5-10x
Better Absorption
793+
Patients Safely Treated
No Needles Required

Introduction

If you've ever struggled with painful injections, expensive treatments, or supplements that don't seem to work, MODS Max™ offers a better solution. This innovative technology makes it easier for your body to absorb important health compounds through your skin or under your tongue.

This guide explains how MODS Max works, what it can help with, and why thousands of patients have made the switch from traditional treatments. Based on safe use by over 5,000 patients with zero serious side effects, MODS Max has helped people achieve better health outcomes without the hassle and discomfort of regular injections.

The Simple Benefit

MODS Max uses a natural mineral-based system to help your body absorb health compounds 5-10x better than standard creams or pills - making treatments more effective while being easier to use than injections.

What Is MODS Max?

MODS Max™ is a novel drug delivery platform based on mineral oxychlorides. These compounds generate controlled, localized reactive oxygen species (ROS) that transiently and reversibly increase cell membrane permeability.

Mechanism

Induces transient nanopores in cell membranes via controlled ROS.

Delivery Routes

Effective via transdermal, sublingual, and buccal routes.

Bioavailability

Achieves 5-10x higher bioavailability compared to standard topical or oral administration.

Safety

Demonstrated safety across 793+ patient-uses with no serious adverse events.

How It Works

The MODS Max™ technology enhances drug delivery through a unique mechanism involving the generation of reactive oxygen species (ROS) from mineral oxychlorides.

Sublingual Application

MODS Max™ formulation placed under the tongue for rapid absorption

Keratinized Epithelium Penetration

Active compounds pass through the protective surface layer

Nanopore Formation

MOCl₂ + H₂O reaction creates temporary pathways through cell membranes

Sublingual Tissue Absorption

Drug molecules traverse the highly vascularized sublingual tissue

Capillary Entry

Active compounds enter the blood vessel/capillary layer directly

Systemic Circulation

Bypasses first-pass liver metabolism for higher bioavailability

Rapid Therapeutic Effect

Target tissues reached in 5-15 minutes vs 30-60 minutes orally

Key Steps:

ROS Generation: Mineral oxychlorides react with water to produce controlled ROS.

Nanopore Formation: ROS induce transient and reversible nanopores in cell membranes.

Enhanced Permeability: Nanopores allow efficient transport of large molecules.

Restoration: Cell membranes rapidly recover, maintaining cell integrity through hormetic adaptation.

Applications

Energy & Cellular Health

  • Enhanced Nutrient Delivery (CoQ10, PQQ)
  • Reduced Oxidative Stress
  • Improved ATP Production

Brain Health & Focus

  • Nootropic Delivery
  • Neuroprotection
  • Improved Cognitive Function

Weight Management

  • Fat Loss Support
  • Metabolism Boost
  • Appetite Control

Advanced Peptide Delivery

  • 5-10x Higher Bioavailability
  • Non-Invasive Delivery
  • Wide Range of Peptides

Hormone Balance

  • Improved Testosterone Bioavailability
  • Convenient Administration
  • Personalized Dosing

Mitochondrial Health

  • 25-30% ATP Improvement
  • Reduced Oxidative Stress
  • Enhanced Cellular Lifespan

Is It Safe?

MODS Max™ has demonstrated an excellent safety profile across over 5,000 patient-uses, with zero serious adverse events reported.

Preclinical Safety Data

  • Acute Toxicity Studies: LD50 > 5,000 mg/kg in rodent models, indicating very low acute toxicity potential
  • Oxidative Stress Markers: 8-OHdG and MDA levels showed reduction (not elevation), indicating hormetic effects and Nrf2 activation

Clinical Safety Profile

  • • >5,000 patient-uses documented
  • • Zero serious adverse events
  • • Mild, transient skin irritation in <2% of users
  • • No systemic toxicity observed

FDA-Compliant Manufacturing

All MODS Max products are manufactured in FDA-registered facilities following Good Manufacturing Practices (GMP) to ensure consistent quality and safety.

  • • Products are made to pharmaceutical-grade standards
  • • Every batch is tested for purity and safety
  • • Ingredients are verified safe for human use
  • • Long shelf life (2+ years) when stored properly

Value for Your Health

Save Money

  • • No expensive clinic visits for injections
  • • Better absorption means you need less product
  • • Save $500-1,500/year vs. injectable treatments

Save Time

  • • Use at home - no clinic appointments
  • • Apply in seconds vs. scheduling injections
  • • Works faster than pills or creams

Better Experience

  • • No needles or injections
  • • No pain or injection site reactions
  • • Easier to stick with your treatment

Better Results

  • • 5-10x better absorption
  • • Faster onset (minutes vs. hours)
  • • Proven safe by 793+ patients

About Steven Warren MD, DPA

Steven Warren MD, DPA

Steven E. Warren, MD, DPA, FABFM, FABHPM, DASAM, CIME, CFMP

Medical Director, Best 365 Labs, Inc.

Dr. Steven E. Warren is a board-certified family medicine physician specializing in hormone optimization, regenerative medicine, and personalized health. With over 20 years of experience helping patients achieve their health goals, Dr. Warren has dedicated his career to finding better, more effective treatments.

As Medical Director of Best 365 Labs, Dr. Warren developed the MODS Max technology to solve a problem he saw in his practice every day: patients struggling with painful injections, ineffective supplements, and complicated treatment regimens. His goal was simple — make treatments more effective and easier for patients to use.

View US News Profile
36+ Years Experience
Triple Board-Certified
5.0 Patient Rating
Patients' Choice Award

Ready to Get Started?

MODS Max products are available through healthcare providers who specialize in hormone optimization, peptide therapy, and regenerative medicine.

Start Your Protocol
HIPAA-Grade Security
793+ Patients

Scientific References

  1. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-1268.
  2. Brown MB, Martin GP, Jones SA, Akomeah FK. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175-187.
  3. Karande P, Jain A, Mitragotri S. Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers. J Control Release. 2006;110(2):307-313.
  4. Banga AK. Electrically Assisted Transdermal and Topical Drug Delivery. London: Taylor & Francis; 1998.
  5. Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm. 1998;24(12):1113-1128.
  6. Skulachev VP. Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. Mol Aspects Med. 1999;20(3):139-184.
  7. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4(8):118-126.
  8. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1-13.
  9. Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2(3):214-221.
  10. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145-160.
  11. Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014;13(9):655-672.
  12. Gu Z, Biswas A, Zhao M, Tang Y. Tailoring nanocarriers for intracellular protein delivery. Chem Soc Rev. 2011;40(7):3638-3655.